CXCL8 and neoplasm: Blockade of IL-8 signaling significantly improved the cytotoxic effect of the chemotherapeutic drugs (Figure 6B), reinforcing the idea that activation of the IL-8 axis in erlotinib-resistant cells imparts multidrug resistance traits, potentially due to their acquisition of a more mesenchymal-like tumor phenotype.